Kaleido Biosciences Inc (KLDO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

18 CROSBY DRIVE BEDFORD, MA 01730

Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company has built a proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT™). MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the gut's existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.

Data as of 2021-09-19 13:18:58 -0400
Market Cap248.227 Million Shares Outstanding42.578 Million Avg 30-day Volume116.929 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.06 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.67419 52-week High/Low20.5 / 5.04 Next Earnings Date2021-11-02 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from KLDO instead.

View recent insider trading info

Funds Holding KLDO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KLDO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MENICHELLA DANIEL L CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
110,000 2021-09-01 5

DUKE WILLIAM E. CHIEF FINANCIAL OFFICER

  • Officer
60,000 2021-09-01 3

KORN JERALD GENERAL COUNSEL

  • Officer
100,000 2021-09-01 3

VAN HYLCKAMA VLIEG JOHAN CHIEF SCIENTIFIC OFFICER

  • Officer
40,000 2021-09-01 2

MELAS KYRIAZI THEO

  • Director
15,000 2021-06-30 1

BONNEY MICHAEL W

  • Director
30,000 2021-06-30 1

QUINN ANTHONY G.

  • Director
15,000 2021-06-30 1

MIXER JEAN K

  • Director
15,000 2021-06-30 1

BASSLER BONNIE L

  • Director
15,000 2021-06-30 1

BURNETT GRADY

  • Director
15,000 2021-06-30 1

VON MALTZAHN GEOFFREY

  • Director
15,000 2021-06-30 1

PRENER ANNE

  • Director
15,000 2021-06-30 1

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

NUTRITIONAL HEALTH LTP FUND, L.P.

AFEYAN NOUBAR

  • 10% Owner
19,575,710 2021-02-08 1

KNOBIL KATHARINE CHIEF MEDICAL OFFICER

  • Officer
0 2020-10-15 1

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

AFEYAN NOUBAR

  • 10% Owner
19,360,710 2020-06-04 1

NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

NUTRITIONAL HEALTH LTP FUND, L.P.

  • 10% Owner
666,666 2020-06-04 0

LAWTON ALISON FRANCES SEE REMARKS

  • Officer
  • Director
0 2020-04-15 0

SCALZO RICHARD WILLIAM PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2019-10-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MENICHELLA DANIEL L - Director - Officer CHIEF EXECUTIVE OFFICER

2021-09-02 16:14:52 -0400 2021-09-01 A 110,000 a 110,000 direct

KORN JERALD - Officer GENERAL COUNSEL

2021-09-02 16:20:16 -0400 2021-09-01 A 100,000 a 100,000 direct

DUKE WILLIAM E. - Officer CHIEF FINANCIAL OFFICER

2021-09-02 16:16:58 -0400 2021-09-01 A 60,000 a 60,000 direct

VAN HYLCKAMA VLIEG JOHAN - Officer CHIEF SCIENTIFIC OFFICER

2021-09-02 16:23:25 -0400 2021-09-01 A 40,000 a 40,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 22:15:03 UTC -3.6362 3.7062 45000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 21:45:03 UTC -3.6362 3.7062 45000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 21:15:03 UTC -3.6362 3.7062 45000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 20:45:02 UTC -3.6383 3.7083 45000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 20:15:03 UTC -3.6383 3.7083 45000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 19:45:03 UTC -3.6383 3.7083 45000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 19:15:03 UTC -3.6383 3.7083 45000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 18:45:03 UTC -3.6384 3.7084 35000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 18:15:04 UTC -3.6384 3.7084 35000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 17:45:04 UTC -3.6384 3.7084 35000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 17:15:03 UTC -3.6384 3.7084 35000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 16:45:03 UTC -3.6218 3.6918 35000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 16:15:03 UTC -3.6218 3.6918 35000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 15:45:03 UTC -3.6218 3.6918 35000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 15:15:03 UTC -3.6218 3.6918 35000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 14:45:03 UTC -3.7274 3.7974 35000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 14:15:03 UTC -3.7274 3.7974 25000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 13:45:04 UTC -3.7274 3.7974 25000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 13:15:03 UTC -3.7274 3.7974 20000
KALEIDO BIOSCIENCES INC KLDO 2021-09-22 12:45:03 UTC -3.7274 3.7974 20000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments